Andreeva Kalina, Zhang Meixia, Fan Wei, Li Xiaohong, Chen Yinlu, Rebolledo-Mendez Jovan D, Cooper Nigel G
Department of Anatomical Sciences and Neurobiology, University of Louisville, School of Medicine, Louisville, KY, USA.
Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Ophthalmol Eye Dis. 2014 Aug 25;6:43-54. doi: 10.4137/OED.S17671. eCollection 2014.
Ischemia/reperfusion (IR) injury has been associated with several retinal pathologies, and a few genes/gene products have been linked to IR injury. However, the big picture of temporal changes, regarding the affected gene networks, pathways, and processes remains to be determined. The purpose of the present study was to investigate initial, intermediate, and later stages to characterize the etiology of IR injury in terms of the pathways affected over time. Analyses indicated that at the initial stage, 0-hour reperfusion following the ischemic period, the ischemia-associated genes were related to changes in metabolism. In contrast, at the 24-hour time point, the signature events in reperfusion injury include enhanced inflammatory and immune responses as well as cell death indicating that this would be a critical period for the development of any interventional therapeutic strategies. Genes in the signal transduction pathways, particularly transmitter receptors, are downregulated at this time. Activation of the complement system pathway clearly plays an important role in the later stages of reperfusion injury. Together, these results demonstrate that the etiology of injury related to IR is characterized by the appearance of specific patterns of gene expression at any given time point during retinal IR injury. These results indicate that evaluation of treatment strategies with respect to time is very critical.
缺血/再灌注(IR)损伤与多种视网膜病变有关,并且一些基因/基因产物已被证明与IR损伤有关。然而,关于受影响的基因网络、信号通路和生物学过程的时间变化全貌仍有待确定。本研究的目的是调查缺血再灌注损伤的初始、中期和后期阶段,以根据随时间变化而受影响的信号通路来描述IR损伤的病因。分析表明,在初始阶段,即缺血期后的0小时再灌注时,与缺血相关的基因与代谢变化有关。相比之下,在24小时时间点,再灌注损伤的标志性事件包括炎症和免疫反应增强以及细胞死亡,这表明这将是任何干预性治疗策略发展的关键时期。此时,信号转导通路中的基因,特别是递质受体,表达下调。补体系统通路的激活在再灌注损伤的后期显然起着重要作用。总之,这些结果表明,与IR相关的损伤病因在视网膜IR损伤的任何给定时间点都具有特定的基因表达模式。这些结果表明,针对时间来评估治疗策略非常关键。